143 related articles for article (PubMed ID: 28333413)
1. Extramedullary leukemia in children with acute myeloid leukemia: A population-based cohort study from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).
Støve HK; Sandahl JD; Abrahamsson J; Asdahl PH; Forestier E; Ha SY; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Zeller B; Hasle H
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28333413
[TBL] [Abstract][Full Text] [Related]
2. Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children's Cancer Group.
Dusenbery KE; Howells WB; Arthur DC; Alonzo T; Lee JW; Kobrinsky N; Barnard DR; Wells RJ; Buckley JD; Lange BJ; Woods WG
J Pediatr Hematol Oncol; 2003 Oct; 25(10):760-8. PubMed ID: 14528097
[TBL] [Abstract][Full Text] [Related]
3. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review.
Byrd JC; Edenfield WJ; Shields DJ; Dawson NA
J Clin Oncol; 1995 Jul; 13(7):1800-16. PubMed ID: 7602369
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is associated with infancy and trisomy 19: Data from Nordic Society for Pediatric Hematology and Oncology (NOPHO-AML) and review of the literature.
Espersen ADL; Noren-Nyström U; Abrahamsson J; Ha SY; Pronk CJ; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Zeller B; Palmqvist L; Hasle H
Genes Chromosomes Cancer; 2018 Jul; 57(7):359-365. PubMed ID: 29569294
[TBL] [Abstract][Full Text] [Related]
5. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.
Byrd JC; Weiss RB; Arthur DC; Lawrence D; Baer MR; Davey F; Trikha ES; Carroll AJ; Tantravahi R; Qumsiyeh M; Patil SR; Moore JO; Mayer RJ; Schiffer CA; Bloomfield CD
J Clin Oncol; 1997 Feb; 15(2):466-75. PubMed ID: 9053467
[TBL] [Abstract][Full Text] [Related]
6. CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group.
Matsuo H; Nakamura N; Tomizawa D; Saito AM; Kiyokawa N; Horibe K; Nishinaka-Arai Y; Tokumasu M; Itoh H; Kamikubo Y; Nakayama H; Kinoshita A; Taga T; Tawa A; Taki T; Tanaka S; Adachi S
Pediatr Blood Cancer; 2016 Aug; 63(8):1394-9. PubMed ID: 27135782
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups.
Creutzig U; Dworzak MN; Zimmermann M; Reinhardt D; Sramkova L; Bourquin JP; Hasle H; Abrahamsson J; Kaspers G; van den Heuvel MM; Reedijk AMJ; De Moerloose B; Locatelli F; Masetti R
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598536
[TBL] [Abstract][Full Text] [Related]
8. Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: a report from the Children's Oncology Group.
Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
Pediatr Blood Cancer; 2012 Apr; 58(4):519-24. PubMed ID: 21618422
[TBL] [Abstract][Full Text] [Related]
9. Is acute myeloid leukemia a liquid tumor?
Ohanian M; Faderl S; Ravandi F; Pemmaraju N; Garcia-Manero G; Cortes J; Estrov Z
Int J Cancer; 2013 Aug; 133(3):534-43. PubMed ID: 23280377
[TBL] [Abstract][Full Text] [Related]
10. Acute Myeloid Leukemia in Adolescents and Young Adults Treated in Pediatric and Adult Departments in the Nordic Countries.
Wennström L; Edslev PW; Abrahamsson J; Nørgaard JM; Fløisand Y; Forestier E; Gustafsson G; Heldrup J; Hovi L; Jahnukainen K; Jonsson OG; Lausen B; Palle J; Zeller B; Holmberg E; Juliusson G; Stockelberg D; Hasle H; ; ;
Pediatr Blood Cancer; 2016 Jan; 63(1):83-92. PubMed ID: 26281822
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
[TBL] [Abstract][Full Text] [Related]
12. Acute Myeloid Leukemia With Central Nervous System Involvement in Children: Experience From the French Protocol Analysis ELAM02.
Felix A; Leblanc T; Petit A; Nelkem B; Bertrand Y; Gandemer V; Sirvent A; Paillard C; Schmitt C; Rohrlich PS; Fenneteau O; Ragu C; Michel G; Auvrignon A; Baruchel A; Leverger G
J Pediatr Hematol Oncol; 2018 Jan; 40(1):43-47. PubMed ID: 29189507
[TBL] [Abstract][Full Text] [Related]
13. Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia.
Bisschop MM; Révész T; Bierings M; van Weerden JF; van Wering ER; Hählen K; van der Does-van den Berg A
Leukemia; 2001 Jan; 15(1):46-9. PubMed ID: 11243398
[TBL] [Abstract][Full Text] [Related]
14. Renal, gastrointestinal, and hepatic late effects in survivors of childhood acute myeloid leukemia treated with chemotherapy only--a NOPHO-AML study.
Skou AS; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros-Svennilson J; Nysom K; Hasle H;
Pediatr Blood Cancer; 2014 Sep; 61(9):1638-43. PubMed ID: 24760750
[TBL] [Abstract][Full Text] [Related]
15. Myeloid Sarcoma Predicts Superior Outcome in Pediatric AML; Can Cytogenetics Solve the Puzzle?
Pramanik R; Tyagi A; Chopra A; Kumar A; Vishnubhatla S; Bakhshi S
Clin Lymphoma Myeloma Leuk; 2018 Jun; 18(6):e249-e254. PubMed ID: 29680411
[TBL] [Abstract][Full Text] [Related]
16. Effect of age and body weight on toxicity and survival in pediatric acute myeloid leukemia: results from NOPHO-AML 2004.
Løhmann DJ; Abrahamsson J; Ha SY; Jónsson ÓG; Koskenvuo M; Lausen B; Palle J; Zeller B; Hasle H
Haematologica; 2016 Nov; 101(11):1359-1367. PubMed ID: 27470605
[TBL] [Abstract][Full Text] [Related]
17. Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial.
Quarello P; Fagioli F; Basso G; Putti MC; Berger M; Luciani M; Rizzari C; Menna G; Masetti R; Locatelli F
Br J Haematol; 2015 Nov; 171(4):566-73. PubMed ID: 26223157
[TBL] [Abstract][Full Text] [Related]
18. Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia.
Ge L; Ye F; Mao X; Chen J; Sun A; Zhu X; Qiu H; Jin Z; Miao M; Fu C; Ma X; Chen F; Xue S; Ruan C; Wu D; Tang X
Biol Blood Marrow Transplant; 2014 Jul; 20(7):1040-7. PubMed ID: 24704575
[TBL] [Abstract][Full Text] [Related]
19. Residual disease detected by flow cytometry is an independent predictor of survival in childhood acute myeloid leukaemia; results of the NOPHO-AML 2004 study.
Tierens A; Bjørklund E; Siitonen S; Marquart HV; Wulff-Juergensen G; Pelliniemi TT; Forestier E; Hasle H; Jahnukainen K; Lausen B; Jonsson OG; Palle J; Zeller B; Fogelstrand L; Abrahamsson J
Br J Haematol; 2016 Aug; 174(4):600-9. PubMed ID: 27072379
[TBL] [Abstract][Full Text] [Related]
20. Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia.
Kobayashi R; Tawa A; Hanada R; Horibe K; Tsuchida M; Tsukimoto I;
Pediatr Blood Cancer; 2007 Apr; 48(4):393-8. PubMed ID: 16550530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
